RxDoctor Payments Data

Katrina Kemp, PA

Physician Assistant · Brandon, FLNPI 1104944396

Payments from drug & device makers

$16,962in general payments, 2019–2025

Across 989 payments — averaging $17.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$4K
  • UCB, Inc.$2K
  • AbbVie$2K
  • Johnson & Johnson$1K
  • AstraZeneca$1K
  • Novartis$1K
  • plus $6K from 19 others

What the payments were for

  • Food & beverage$16,962100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,962 in reported general payments places this provider in the 95th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$178,918
Medicare patients
462
Services billed
3,243

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab56$460,147
Orencia ClickjectAbatacept13$90,896
Enbrel SureclickEtanercept11$84,778
TymlosAbaloparatide15$55,622
Teriparatide24$42,526
Hydroxychloroquine Sulfate605$25,992
MethotrexateMethotrexate Sodium367$8,895
Cevimeline Hcl25$5,718
Gabapentin213$3,775
Leflunomide53$3,197
Diclofenac Sodium31$2,464
Duloxetine Hcl114$2,086
Prednisone208$1,853
Methylprednisolone181$1,512
Tizanidine Hcl65$1,460

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Radius Health, Inc.Tymlos$445$55,62215 claims
Scilex Pharmaceuticals Inc.Colchicine$42$68411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Brandon

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →